The hardware and bandwidth for this mirror is donated by METANET, the Webhosting and Full Service-Cloud Provider.
If you wish to report a bug, or if you are interested in having us mirror your free-software or open-source project, please feel free to contact us at mirror[@]metanet.ch.

GSSTDA: Progression Analysis of Disease with Survival using Topological Data Analysis

Mapper-based survival analysis with transcriptomics data is designed to carry out. Mapper-based survival analysis is a modification of Progression Analysis of Disease (PAD) where survival data is taken into account in the filtering function. More details in: J. Fores-Martos, B. Suay-Garcia, R. Bosch-Romeu, M.C. Sanfeliu-Alonso, A. Falco, J. Climent, "Progression Analysis of Disease with Survival (PAD-S) by SurvMap identifies different prognostic subgroups of breast cancer in a large combined set of transcriptomics and methylation studies" <doi:10.1101/2022.09.08.507080>.

Version: 1.0.0
Depends: R (≥ 3.5.0)
Imports: base, cluster, stats, survival, utils, visNetwork, ComplexHeatmap, circlize, devtools
Suggests: rmarkdown, knitr, testthat (≥ 3.0.0)
Published: 2024-06-01
DOI: 10.32614/CRAN.package.GSSTDA
Author: Miriam Esteve ORCID iD [aut, cre], Raquel Bosch [aut], Jaume Forés ORCID iD [aut], Joan Climent [aut], Antonio Falco [aut]
Maintainer: Miriam Esteve <miriam.estevecampello at uchceu.es>
License: GPL-3
NeedsCompilation: no
Materials: README
CRAN checks: GSSTDA results

Documentation:

Reference manual: GSSTDA.pdf
Vignettes: GSSTDA-vignette

Downloads:

Package source: GSSTDA_1.0.0.tar.gz
Windows binaries: r-devel: GSSTDA_1.0.0.zip, r-release: GSSTDA_1.0.0.zip, r-oldrel: GSSTDA_1.0.0.zip
macOS binaries: r-release (arm64): GSSTDA_1.0.0.tgz, r-oldrel (arm64): GSSTDA_1.0.0.tgz, r-release (x86_64): GSSTDA_1.0.0.tgz, r-oldrel (x86_64): GSSTDA_1.0.0.tgz
Old sources: GSSTDA archive

Linking:

Please use the canonical form https://CRAN.R-project.org/package=GSSTDA to link to this page.

These binaries (installable software) and packages are in development.
They may not be fully stable and should be used with caution. We make no claims about them.